Tolerance, dependence and withdrawal
Tolerance, dependence and withdrawal. Define physical dependence, tolerance and cannabis withdrawal syndrome using current diagnostic frameworks.
Tolerance, dependence and withdrawal are related but not interchangeable. Tolerance describes a reduced response after repeated exposure. Physical dependence means adaptation can produce withdrawal after stopping or making a substantial reduction. Cannabis use disorder is a broader clinical diagnosis involving patterns of use and harm; dependence alone does not establish it.
Tolerance, dependence and withdrawal: Cannabis withdrawal: what reviews show
A 2022 clinical review describes cannabis withdrawal as a well-characterised response that occurs in about half of regular or dependent users after abrupt cessation or a substantial reduction in THC-containing cannabis. A 2020 meta-analysis of 47 studies and 23,518 participants estimated a pooled prevalence of 47%, with large differences between population, outpatient and inpatient samples. Those estimates concern regular or dependent use and should not be applied to every person with a prescription.
Commonly reported features include irritability, anxiety, anger or aggression, disturbed sleep or dreams, depressed mood and reduced appetite. Less common physical features include chills, headache, sweating, physical tension and stomach pain. The 2022 review reports that symptoms often begin 24 to 48 hours after cessation and commonly peak on days two to six. Some symptoms can last three weeks or longer in heavy users.
These are population patterns, not a timetable for an individual. Product composition, frequency and duration of use, other substances, mental health and the condition being treated can all change what happens.
Dependence is not the same as addiction
Physical adaptation can occur with prescribed medicines. Cannabis use disorder involves a wider pattern such as impaired control, continued use despite harm or significant disruption to responsibilities and relationships. Only a qualified clinician can assess those features in context.
Avoid two opposite mistakes: treating every withdrawal symptom as proof of addiction, or assuming prescribed use cannot lead to tolerance or dependence. A prescription changes the legal and clinical context; it does not make physiological adaptation impossible.
Planning a reduction with a prescriber
The evidence review identifies supportive counselling and psychoeducation as first-line management. It also notes that no medicine is specifically approved for medically assisted cannabis withdrawal. That does not support a universal percentage taper or a fixed calendar copied from the internet.
Before reducing or stopping a prescribed product, tell the prescriber:
- the exact product, route, amount and pattern of use;
- other prescribed, over-the-counter or recreational substances;
- previous withdrawal or difficulty reducing;
- sleep, mood or anxiety concerns;
- responsibilities affected by poor sleep or concentration;
- what condition the product was intended to manage.
Ask for a written, individual plan and a contact point if symptoms become difficult. People with significant mental-health conditions, polysubstance use or previous complicated withdrawal may need closer clinical support; the appropriate setting is a clinical decision.
When to seek prompt help
Contact the prescriber or an urgent health service if symptoms are severe, functioning deteriorates, another substance may also be involved, or there are concerns about safety. Immediate danger, severe confusion, psychosis or thoughts of self-harm require urgent assessment through local emergency or crisis services.
Record observations without self-diagnosing
A short record can help a clinician distinguish timing from assumption. Note when the prescribed product was used or changed, sleep and appetite changes, mood symptoms, other medicines or substances, and any effect on work, caregiving or driving. Record what happened rather than labelling it “withdrawal” in advance.
Bring the record to the review. Symptoms may reflect withdrawal, the condition originally being treated, another medicine, sleep loss or an unrelated illness. The pattern and clinical context matter more than a checklist score copied from a website. Do not use the record to design a taper or restart schedule without the prescriber.
The safe takeaway is not “stop abruptly” or “taper by a fixed percentage.” It is to recognise possible withdrawal, distinguish it from the underlying condition, and plan any meaningful change with the clinician responsible for the prescription.
Frequently Asked Questions
How long does cannabis withdrawal last?
Withdrawal symptoms typically begin 1-2 days after stopping heavy use, peak between days 2 and 6, and last 1-3 weeks (DSM-5-TR, 2022). Sleep disturbance may persist for more than 30 days in some people.
Can I stop my medicinal cannabis suddenly?
Abrupt cessation after prolonged heavy use can trigger a clinically significant withdrawal syndrome (DSM-5-TR, 2022). Discuss a gradual dose taper with your prescriber before stopping or reducing (Healthify, 2023).
Is dependence the same as addiction?
No. Dependence is a neuro-adaptation that leads to withdrawal on cessation; addiction is a behavioural syndrome of compulsive use despite harm (DSM-5-TR, 2022). You can be dependent without being addicted.
What should I do if I feel irritable or depressed after reducing my dose?
These are common withdrawal symptoms (DSM-5-TR, 2022). Plan extra support during the first two weeks, avoid caffeine, and report suicidal ideation or severe depression to your prescriber immediately (Healthify, 2023).
Read next
-
Side effects and red flags
Medicinal cannabis in New Zealand, like any prescribed medicine, can cause side effects.
-
Driving and safety-sensitive work
If you use medicinal cannabis in New Zealand and drive, or work in a safety-sensitive role, the legal line is not whether a doctor has signed a script. It is whether you are impaired.
-
Pregnancy, breastfeeding and young people
If you are pregnant, planning a pregnancy, breastfeeding, or under 25, the safe default with medicinal cannabis is the same: do not start it, and if you are already prescribed it, talk to…
-
Safe storage at home
Keeping medicinal cannabis secure in a New Zealand home is not about hiding it from visitors.
-
Science and the New Zealand sector
Medicinal cannabis in New Zealand is a regulated pharmaceutical pathway, not a general licence to use cannabis.